Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Vous n'êtes pas connecté
Two studies published in the latest issue of the journal Cell by University of Pittsburgh researchers in the USA, uncover how immunotherapies targeting the immune checkpoints PD1 and LAG3 work together to activate immune responses. The findings shed light on why combination therapies targeting both checkpoints can improve outcomes for melanoma patients compared to monotherapies targeting [...]
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
Immune checkpoint inhibitors are a type of cancer treatment that helps the immune system attack cancer cells more effectively. One of the key proteins...
The immune system is mainly responsible for identifying germs and viruses and initiating long-lasting immune responses against them. On the other...
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...
Researchers at The University of Queensland are developing a comprehensive paediatric immune cell ‘atlas’ to aid in the diagnosis and treatment of...
The main text of the study details the experiments conducted to understand the role of IL-24 in AD-like conditions. It describes the methods used,...
Table salt (sodium chloride) can activate immune cells and destroy cancer cells, discovers a new study. The findings of the study are published in...
Findings indicate that testosterone therapy in trans men alters immune system responses, suggesting implications for disease susceptibility and...
Scientists at the University of Southampton have uncovered how the immune system's natural killer cells can target a protein known as XPO1, which...
Immune checkpoint inhibitors are cancer-fighting drugs that help the immune system do its job of detecting and attacking tumour cells. Programmed Cell...